Immatics N.v. buy BiotechBee
Start price
07.09.22
/
60%
€13.10
Target price
31.12.24
€18.00
Performance (%)
-32.14%
End price
05.05.23
€8.89
Summary
This prediction ended on 05.05.23 with a price of €8.89. The BUY prediction by BiotechBee for Immatics N.v. performed very badly with a performance of -32.14%. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Immatics N.v. | - | - | - |
iShares Core DAX® | 1.776% | 3.175% | 14.882% |
iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% |
iShares Nikkei 225® | -0.335% | 3.857% | 14.485% |
iShares S&P 500 | 0.854% | 2.567% | 31.105% |
According to BiotechBee what are the pros and cons of Immatics N.v. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Immatics N.v. diskutieren
Buy mit Kursziel 18,0
In the thread Trading Immatics N.v.
Buy beendet